Best Nanotechnology Companies in Australia
The 33 best Nanotechnology companies in Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Vaxxas.
Our analysis of 50 Nanotechnology companies
$6.5b in tracked funding; 78% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Nanotechnology companies in Australia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vaxxas Developer of a needle-free patch technology for vaccine delivery applications 57News top 17%Funding top 23%Growth top 25%Moat top 39% All 8 signals ▾Newstop 17% Fundingtop 23% Growthtop 25% Moattop 39% Talenttop 45% Markettop 50% Techbottom 36% Globalbottom 36% News: 11 BI events in 12 mo (of 30 tracked, 6 types) · +1000% YoY Funding: Raised $59.3M across 9 rounds · 9 rounds over 15 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 57/100 | $59M | 14 mo ago | Series D | David Peacock CEO | 2010 | PHPBootstrapLiteSpeed+10 | 10 signals ▲67% Leadership · Regulatory | — | — |
| 2 | EnGeneIC Developer of targeted anti-cancer therapies using nanocell platform technology | $25M | 115 mo ago | Series B | — | 2000 | — | — | — | — |
| 3 | Anteo Tech Supplier of advanced material solutions in the battery materials and life sciences markets 48Product top 14%Funding top 31%Patents top 33%Moat top 38% All 11 signals ▾Producttop 14% Fundingtop 31% Patentstop 33% Moattop 38% Innovationtop 39% Techtop 39% Partnerstop 41% Marketbottom 42% Growthbottom 40% Globalbottom 40% Newsbottom 24% Product: 5 distinct product lines · Company stage: Public Funding: Raised $18.7M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $19M | 24 mo ago | Public | — | 1995 | WordPressMySQLSalesforce+23 | — | 91 patents Advanced conductive binder and composite materials for battery electrodes | — |
| 4 | Antisense Therapeutics Developer of RNA-based antisense drugs | $10M | 71 mo ago | Public | — | 2001 | — | — | 123 patents Antisense oligonucleotide therapeutics for neurodegenerative and muscular disease treatment | — |
| 5 | Ellume Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing | $5M | 69 mo ago | Series A | Sean Parsons Founder & MD | 2010 | WordPressMySQLPHP+16 | — | 52 patents Fluorescent lateral‑flow diagnostic devices and sample collection for rapid pathogen testing | — |
| 6 | Nano-Nouvelle Provider of nanomaterials as a platform technology for cross industry applications | $5M | 136 mo ago | Deadpooled | — | 2007 | — | — | 25 patents Advanced porous electrode materials and thin-film coatings for high-performance batteries. | — |
| 7 | Nanollose Provider of fiber based on nanocellulose technology 40Patents top 28%Moat top 32%Growth top 35%Innovation top 40% All 9 signals ▾Patentstop 28% Moattop 32% Growthtop 35% Innovationtop 40% Fundingtop 46% Talentbottom 49% Techbottom 45% Globalbottom 37% Marketbottom 25% Patents: 29 patents matched (strict assignee match) · 16 filings since 2022 vs 13 in 2017-21 Moat: Editorial + unicorn rating 5/10 · IP moat: 29 patents rank vs industry peers · Fliar Intelligence Index 40/100 | $5M | 21 mo ago | Public | Alfie Germano CEO | 2014 | WordPressMySQLPHP+22 | — | 29 patents High‑strength regenerated cellulose fibers and microbial cellulose dewatering for agricultural media | — |
| 8 | Sparc Technologies Developer of graphene additives and green hydrogen technology for sustainability | $3M | 30 mo ago | Public | — | 1984 | WordPressMySQLPHP+25 | — | — | — |
| 9 | GMG Manufacturer of graphene and graphene-based products | $2M | 38 mo ago | Series C | — | 2018 | Cart FunctionalityWordPressMySQL+38 | 16 signals ▼27% Regulatory · Funding · Contracts | — | — |
| 10 | Imagine Intelligent Materials Develop coatings using graphene for various applications. | $2M | 78 mo ago | Seed | Drew (Andrew) Williams Co-Founder | 2014 | — | — | — | — |
Top 12 Nanotechnology companies in Australia
#1
Series D · Brisbane, Queensland · founded 2010 · 113 employees$59.3Mraised▾
Developer of a needle-free patch technology for vaccine delivery applications. The company’s technology uses a patch with microprojections applied to the skin. This approach aims to enhance vaccine efficiency and effectiveness. The company’s dry-coating technology reduces the need for vaccine refrigeration during storage and transport. The company targets applications in infectious disease and oncology.
- Aug 2025Conventional Debt$25.2M
- Aug 2025Series D$31.9M
- Dec 2022Series C$23M
- Sep 2022Grant (prize money)$5.5M
#2
Public · Nedlands, Western Australia · founded 2014$4.8Mraised▾
Nanollose provides fiber based on nanocellulose technology. Its product Rayon Fiber is a fiber made of plant-free microbial cellulose that is derived from biomass waste products from beer, wine, and liquid food. It uses its proprietary technology for the production, processing, and application of microbial nanocellulose. Its products have application in cotton and linen textiles, cellophane, paper industry, horticulture, and clothing industry.
- Feb 2025Post IPO$1.9M
- Apr 2021Post IPO$2.9M
#3
Public · Eight Mile Plains, Queensland · founded 1995 · 40 employees$18.7Mraised▾
Supplier of advanced material solutions in the battery materials and life sciences markets. Its product Mix&Go consist of a liquid coating reagent which allows modification of both flat surfaces or beads within 60 minutes. The reagents consist of metal polymers which allows binding to negatively charged residues on proteins, which doesn't allow denaturation of proteins on immobilization. Another product AMG kits consist of liquid coating reagent along with optimized buffers, and low binding microcentrifuge tubes. In addition, company offers a number of kits specifically for applications like biosensor, lateral flow, etc.
- Oct 2024Post IPO$4M
- Apr 2024Post IPO$5.4M
- Apr 2021Post IPO$9.3M
#4
Public · Kent Town, South Australia · founded 1984 · 6 employees$2.5Mraised▾
Developer of graphene additives and green hydrogen technology for sustainability. The company focuses on renewable energy projects, including green hydrogen and graphene applications. It develops graphene-based additives to enhance marine and protective coatings. Additionally, the company develops graphene-enhanced polymer technology to improve aquaculture netting.
- Apr 2024Post IPO$1.4M
- Oct 2023Grant (prize money)$470.5K
- Sep 2022Grant (prize money)$607K
#5
Series C · Darra, Queensland · founded 2018 · 38 employees$2.1Mraised▾
Manufacturer of graphene and graphene-based products. It provides users with a platform where graphene products are used for concrete strengthening and conductive applications, plastic strengthening and electrical applications including batteries.
- Aug 2023Series C$125.8K
- Nov 2020Series C$1.2M
#6
Series B · Lane Cove, New South Wales · founded 2000 · 30 employees$25.1Mraised▾
Developer of targeted anti-cancer therapies using nanocell platform technology. The company focuses on research, development, and manufacturing. It utilizes a proprietary nanocell platform for targeted delivery of chemotherapeutics and functional nucleic acids. The technology aims to target tumors directly and leverage the patient’s own immune system.
- Apr 2017Series B$150K
- Jul 2015Series B$2.9M
- Dec 2014Series B$10M
- Aug 2014Series A$7M
#7
Public · Toorak, Victoria · founded 2001 · 8 employees$10.1Mraised▾
Developer of RNA-based antisense drugs. The company develops targeted RNA-based antisense drugs. It has four products in its pipeline. Its two lead candidates are in phase III clinical trials for acromegaly and multiple sclerosis. In addition, it has two additional candidates that are in preclinical testing for prostate cancer and asthma.
- Nov 2020Post IPO$7.3M
- Apr 2018Post IPO$581.6K
- Apr 2008Post IPO$2.2M
#8
Series A · Brisbane, Queensland · founded 2010 · 135 employees$5Mraised▾
Ellume has is a developer of a diagnostic device that uses quantum dot fluorescent nanoparticles as biological detectors. It provides real-time patient testing with features such as encrypted patient data and images, connectivity to access user information, and claims to provides results in approximately seven minutes. The company has developed tests for Influenza A+B, Respiratory Syncytial Virus, Group A Streptococcus, and aims to create tests for more respiratory viruses and bacterial infections.
- Feb 2021Grant (prize money)$230M
- Jun 2019Series A$5M
#9
Deadpooled · Sunshine Coast, Queensland · founded 2007 · 11 employees$4.8Mraised▾
Nano-Nouvelle is a provider of nanomaterials as a platform technology for cross-industry applications. It has a 3D nanoporous conductive membrane that offers benefits like electrical conductivity through a complex mesh of surface and a porous structure with a customizable surface area in the range of 0.5 to 5.0 m2/cm3. Its product includes high-performance battery electrodes which are claimed to provide 50% more energy capacity than existing anode technology. It can be used in energy, environmental, chemical, and biomedical applications. It also offers services to coat materials with nano-level layers of atoms known as atomic layer deposition (ALD) in the renewable energy sector.
- Jun 2015Series B$3.7M
- 2013Grant (prize money)$1.3M
- Sep 2011Series A$1.1M
- Apr 2009Grant (prize money)$276.8K
#10
Seed · Sydney, New South Wales · founded 2014 · 11 employees$2Mraised▾
Imagine develops new coatings using graphene for various applications. They work with clients to develop tailored solutions or provide a license of their existing solutions. They have developed coatings using graphene which can be applied to nonwoven geotextiles converting them into a leak detection system. They have also developed sensing systems that allow real-time monitoring of defects, strain, temperature and moisture.Imagine develops new material and products using graphene for various applications. They work with clients to develop tailored solutions or provide a license of their existing solutions. They have developed coatings using graphene which can be applied to nonwoven geotextiles converting them into a leak detection system. They have also developed sensing systems that allow real-time monitoring of defects, strain, temperature and moisture.
- Apr 2020Grant (prize money)—
- Feb 2017Seed$2M
#11
Deadpooled · Melbourne, Victoria · founded 2014$20Kraised▾
Eira Biotech is focused on integrating nanotechnology into innovative solutions for the healthcare industry. The company is currently focusing on improving the treatment of central nervous system (CNS) disorders (e.g., Parkinson's and Alzehimer's) by developing smart therapeutic nanocarriers which bypass the blood-brain barrier and deliver therapeutic biomolecules into the brain.
- May 2015Grant (prize money)$20K
#12
Public · Perth, Western Australia · founded 1920 · 14 employees—raised▾
Manufacturer of a graphene-based product. The product is a powder-based material that enhances the properties of products and materials across industries and applications including composites, elastomers, fire retardancy, energy storage, and concrete.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Nanotechnology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.